Opinion|Videos|June 24, 2024
Differential Diagnosis When Considering Hidradenitis Suppurativa in a Patient
Author(s)Iltefat Hamzavi, MD
A dermatologist provides clinical insights on differential diagnosis strategies when considering hidradenitis suppurativa in patients and the challenges associated with diagnosis.
Advertisement
Episodes in this series
Video content above is prompted by the following questions:
- What is in your differential diagnosis when considering hidradenitis suppurativa (HS) in a patient and how is this disease definitively diagnosed?
- Average delay in HS diagnosis has been found to be around 10 years. What do you think accounts for this and why is it imperative for patients with HS to be diagnosed sooner?
Advertisement
Related Content
Advertisement
Advertisement
Trending on AJMC
1
Medicaid MFN Pricing Could Save $8.6 Billion
2
Cardiology Prices Vary Widely by Insurer and State
3
CRC Treatment Delays Linked to Higher Metastasis Risk, Supporting Pathway-Specific Benchmarks
4
FDA Approves Enlicitide, First Oral PCSK9 for High Cholesterol
5